Ovarian Cancer News

CancerConnect ovarian cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of ovarian cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of ovarian cancer treatment and survivorship.

Share

Ovarian Cancer News


SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment (August 22, 2016)

A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy (NACT) is the optimal first-line... Continue Reading

T-Cells Can be Directed to Treat a Variety of Ovarian Cancers (August 11, 2016)

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the... Continue Reading

Niraparib Improves Progression-Free Survival in Ovarian Cancer (July 13, 2016)

The PARP inhibitor niraparib improves the time to cancer progression among patients with recurrent ovarian cancer when used as maintenance therapy during platinum-based chemotherapy. Each year in the United... Continue Reading

West Los Angeles Premier Cancer Prevention 5K Celebrates 15 Years (July 5, 2016)

The Kickin’ Cancer!® 5K Run / Walk / Stroll is the Lynne Cohen Foundation’s flagship event to end women’s cancers through prevention. As a West Los Angeles favorite since 2001, this event celebrates... Continue Reading

Ask the Lynch Syndrome Expert Q&A Now Available (June 2, 2016)

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez* CancerConnect recently collaborated with the Dana-Farber Cancer Institute to provide you with the opportunity to... Continue Reading

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (May 25, 2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing... Continue Reading

Cancer Survivorship: Managing Hot Flashes (May 23, 2016)

By Barrie Cassileth, MS, PhD Hot flashes are a common side effect of treatment in people with hormone-dependent cancers, such as breast and prostate cancer. Hormone replacement therapy, which may be used... Continue Reading

Lifestyle Factors Influence Age of Breast Cancer Diagnosis Among BRCA1/2 Carriers (April 26, 2016)

Among women with the BRCA1/2 mutations, those who have been pregnant, given birth, not smoked, and/or have not taken oral contraceptives experience a delay in onset of a diagnosis of breast cancer. These... Continue Reading

Lynne Cohen Foundation Launches CancerConnect Social Media Platform for Women Facing Increased Risk for Ovarian and Breast Cancers (April 15, 2016)

Santa Monica, CA/Sun Valley ID– With the launch of the CancerConnect online community, the Lynne Cohen Foundation now offers a specialized social network for women facing increased risk for ovarian and... Continue Reading

NLN Update on the Lymphedema Treatment Act (March 16, 2016)

Updated March 2016 2016 may well be the year that Congress votes to approve the Lymphedema Treatment Act, which provides a Medicare benefit category for essential compression garments and supplies needed... Continue Reading

More Ovarian Cancer News

Latest Ovarian Cancer News By Stage


Screening and Prevention

Ask the Lynch Syndrome Expert Q&A Now Available (June 2, 2016)

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez* CancerConnect recently collaborated with the Dana-Farber Cancer Institute to provide you with the opportunity to engage with a hereditary cancers expert, Kimberly... Continue Reading

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (May 25, 2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing and genetic counseling service, today announced... Continue Reading

Lynne Cohen Foundation Launches CancerConnect Social Media Platform for Women Facing Increased Risk for Ovarian and Breast Cancers (April 15, 2016)

Santa Monica, CA/Sun Valley ID– With the launch of the CancerConnect online community, the Lynne Cohen Foundation now offers a specialized social network for women facing increased risk for ovarian and breast cancers. This community furthers the foundation’s... Continue Reading

Now Available! Ask the Expert: The Latest in Genetics and Women’s Cancers (October 14, 2015)

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Garber   CancerConnect recently partnered with Dana-Farber Cancer Institute to provide you with the opportunity to engage with cancer genetics and prevention expert... Continue Reading

Ovarian Cancer Awareness: Risk, Prevention, Treatment, Survivorship, & Community (September 2, 2015)

As the month of September brings ovarian cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer... Continue Reading

More Screening and Prevention

Stage I

Intraperitoneal Chemotherapy Underused in Ovarian Cancer (September 28, 2015)

The use of intraperitoneal (IP) chemotherapy appears to be utilized in fewer than 50% of clinical practices, despite results indicating improved survival with its use in certain patients with ovarian cancer. These results were recently published in the... Continue Reading

Ovarian Cancer Awareness: Risk, Prevention, Treatment, Survivorship, & Community (September 2, 2015)

As the month of September brings ovarian cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer... Continue Reading

Ovarian Cancer Talk: Participate in a Live Video Chat With the Experts from Roswell Park Cancer Institute (September 22, 2014)

Straight from Roswell Park Cancer Institute in Buffalo, N.Y., to your computer or mobile device, four leading experts in ovarian cancer will broadcast a live, interactive video chat from 6 to 7 p.m. on Monday, September 22, 2014. The multidisciplinary... Continue Reading

National Gynecologic Cancer Awareness Month on CancerConnect (September 9, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of cervical, ovarian and uterine cancer educational programs for national gynecologic cancer awareness month. As the month of September brings gynecologic cancers... Continue Reading

National Ovarian Cancer Awareness Month on CancerConnect (September 2, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of ovarian cancer educational programs for national ovarian cancer awareness month. As the month of September brings ovarian cancer into focus, it’s time to increase... Continue Reading

More Stage I

Stages II-IV

SGO, ASCO Issue New Guidelines for Ovarian Cancer Treatment (August 22, 2016)

A new joint clinical practice guideline from the American Society of Clinical Oncology (ASCO) and the Society of Gynecologic Oncology (SGO) states that neoadjuvant chemotherapy (NACT) is the optimal first-line treatment for some women who have newly diagnosed... Continue Reading

Intraperitoneal Chemotherapy Underused in Ovarian Cancer (September 28, 2015)

The use of intraperitoneal (IP) chemotherapy appears to be utilized in fewer than 50% of clinical practices, despite results indicating improved survival with its use in certain patients with ovarian cancer. These results were recently published in the... Continue Reading

Ovarian Cancer Awareness: Risk, Prevention, Treatment, Survivorship, & Community (September 2, 2015)

As the month of September brings ovarian cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer... Continue Reading

Personalized Immunotherapy Delays Recurrence in Ovarian Cancer (May 11, 2015)

A new immunotherapy known as Vigil™ may help delay the recurrence of advanced ovarian cancer. These findings were presented at the 2015 Annual Meeting on Women’s Cancer, March 28–31, in Chicago, Illinois. According to the American Cancer Society... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (April 29, 2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented at the 2015 Annual Meeting on Women’s Cancer,... Continue Reading

More Stages II-IV

Recurrent

Niraparib Improves Progression-Free Survival in Ovarian Cancer (July 13, 2016)

The PARP inhibitor niraparib improves the time to cancer progression among patients with recurrent ovarian cancer when used as maintenance therapy during platinum-based chemotherapy. Each year in the United States, approximately 22,000 women are diagnosed... Continue Reading

Ovarian Cancer Awareness: Risk, Prevention, Treatment, Survivorship, & Community (September 2, 2015)

As the month of September brings ovarian cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated ovarian cancer... Continue Reading

Drug Rucaparib Promising in Pretreated BRCA-Positive Ovarian Cancer (June 15, 2015)

The drug rucaparib appears active in women with recurrent BRCA-positive ovarian cancer that has progressed after previous treatment. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago,... Continue Reading

Combination of Avastin®, Taxol®, and Carboplatin Improves Survival in Recurrent Platinum-Sensitive Ovarian Cancer (April 29, 2015)

The addition of Avastin® (bevacizumab) to Taxol® (paclitaxel) and carboplatin for the treatment of recurrent platinum-sensitive ovarian cancer appears to improve survival. These findings were presented at the 2015 Annual Meeting on Women’s Cancer,... Continue Reading

Lynparza Approved in Advanced Ovarian Cancer (December 29, 2014)

CancerConnect News: The U.S. Food and Drug Administration has granted accelerated approval to LynparzaTM (olaparib), a new drug treatment for women with advanced ovarian cancer associated with defective BRCA genes. According to statistics from the American... Continue Reading

More Recurrent

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS